Synergy Innovation Co., Ltd. (KOSDAQ:048870)

Revenue by Segment

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015
Biotechnology Business	20.83B	18.17B	13.52B	18.16B	20.60B
Biotechnology Business Growth	14.64%	34.35%	-25.54%	-11.86%	87.26%
Health Function Food Business	14.83B	18.66B	16.80B	12.55B	8.14B
Health Function Food Business Growth	-20.55%	11.11%	33.88%	54.10%	-25.50%
Medical Business	53.75B	48.17B	60.66B	-	40.20B
Medical Business Growth	11.58%	-20.59%	-	-	23.12%
Adjustment and removal	-	-1.79B	-4.44B	-	-
Other	1.20B	-	-	-	-
Total	90.61B	83.21B	86.54B	30.71B	68.95B
Total Growth	8.88%	-3.84%	181.84%	-55.47%	26.31%

Revenue by Geography

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015
Export	-	-	44.17B	34.66B	29.52B
Export Growth	-	-	27.42%	17.41%	21.01%
South Korea	50.10B	52.95B	46.81B	46.23B	39.33B
South Korea Growth	-5.37%	13.11%	1.26%	17.54%	27.50%
Foreign Country	40.50B	32.05B	-	-	-
Foreign Country Growth	26.35%	-	-	-	-
Discontinued Operations	-	-1.79B	-4.44B	-50.19B	-
Total	90.60B	83.21B	86.54B	30.71B	68.86B
Total Growth	8.88%	-3.84%	181.83%	-55.41%	24.63%

Source: S&P Global Market Intelligence.